|
|
Previous Article | Table of Contents | Next Article 
Contact activation triggers stimulation of the monocyte 5-lipoxygenase
pathway via plasmin
I Weide, J Romisch and T Simmet
Department of Pharmacology and Toxicology, Ruhr University, Bochum,
Germany.
The purpose of this study was to characterize the stimulus that activates
the 5-lipoxygenase pathway in human peripheral monocytes (PM) during the
process of contact activation. Incubation of PM, but not of
polymorphonuclear leukocytes (PMN), in contact-activated, recalcified
plasma induced a time-dependent release of leukotrienes (LT). The presence
of platelets was required for the generation of cysteinyl-LT, but LTB4
formation also proceeded in their absence, although to a lesser extent.
Plasmin, presumably generated via the intrinsic fibrinolytic pathway, was
liable for the 5-lipoxygenase stimulation during contact activation
inasmuch as (1) the 5-lipoxygenase pathway in PM was stimulated by
contact-activated, recalcified, autologous or homologous plasma, but not by
factor XII-deficient or prekallikrein- deficient plasma; (2) lysine analogs
such as N alpha-acetyl-L-lysine, 6- aminohexanoic acid (6-AHA), or trans-4-
(aminomethyl)cyclohexane-1- carboxylic acid (t-AMCA), which inhibit
plasmin(ogen) binding to PM plasmin(ogen) binding sites,
concentration-dependently reduced the cysteinyl-LT release; (3) plasminogen
activators such as urokinase or streptokinase concentration-dependently
enhanced the cysteinyl-LT release up to 10 and 1,000 IU/mL, respectively,
while higher concentrations were less effective leading to bell-shaped
concentration- response curves; (4) plasmin inhibitors such as aprotinin or
alpha 2- antiplasmin concentration-dependently inhibited the cysteinyl-LT
release; and (5) preincubation of plasma with monoclonal antibodies
directed against plasminogen and capable of preventing plasminogen
activation blocked the contact-mediated 5-lipoxygenase stimulation.
Moreover, incubation of PM with plasmin, but not with plasma kallikrein, in
Hanks' balanced salt solution (HBSS)-bovine serum albumin (BSA) 0.4%
triggered a concentration-dependent release of LTB4 up to 0.1 caseinolytic
units (CU)/mL, with higher concentrations being less effective. By
contrast, release of cyclooxygenase metabolites such as thromboxane (TX) B2
and prostaglandin (PG) E2 was not stimulated by plasmin, indicating
specificity for the 5-lipoxygenase pathway. With plasmin as a hitherto
unknown stimulus of the 5-lipoxygenase pathway in PM, a novel link between
contact activation and inflammation has been established.
Volume 83,
Issue 7,
pp. 1941-1951,
04/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Renckens, J. M. Pater, and T. v. d. Poll
Plasminogen Activator Inhibitor Type-1-Deficient Mice Have an Enhanced IFN-{gamma} Response to Lipopolysaccharide and Staphylococcal Enterotoxin B
J. Immunol.,
December 1, 2006;
177(11):
8171 - 8176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Renckens, S. Weijer, A. F. de Vos, J. M. Pater, J. C. Meijers, C. E. Hack, M. Levi, and T. van der Poll
Inhibition of Plasmin Activity by Tranexamic Acid Does Not Influence Inflammatory Pathways During Human Endotoxemia
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2004;
24(3):
483 - 488.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Burysek, T. Syrovets, and T. Simmet
The Serine Protease Plasmin Triggers Expression of MCP-1 and CD40 in Human Primary Monocytes via Activation of p38 MAPK and Janus Kinase (JAK)/STAT Signaling Pathways
J. Biol. Chem.,
August 30, 2002;
277(36):
33509 - 33517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Syrovets, M. Jendrach, A. Rohwedder, A. Schule, and T. Simmet
Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK{beta}-mediated NF-{kappa}B activation
Blood,
June 15, 2001;
97(12):
3941 - 3950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Syrovets, J. Thillet, M. J. Chapman, and T. Simmet
Lipoprotein(a) Is a Potent Chemoattractant for Human Peripheral Monocytes
Blood,
September 1, 1997;
90(5):
2027 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Syrovets, B. Tippler, M. Rieks, and T. Simmet
Plasmin Is a Potent and Specific Chemoattractant for Human Peripheral Monocytes Acting Via a Cyclic Guanosine Monophosphate-Dependent Pathway
Blood,
June 15, 1997;
89(12):
4574 - 4583.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|